Your browser doesn't support javascript.
loading
Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
Okuni, Marika; Yakushijin, Kimikazu; Uehara, Keiichiro; Ichikawa, Hiroya; Suto, Hirotaka; Hashimoto, Akiko; Tanaka, Yasuhiro; Shinzato, Isaku; Sakai, Rina; Mizutani, Yu; Nagao, Shigeki; Kurata, Keiji; Kakiuchi, Seiji; Miyata, Yoshiharu; Inui, Yumiko; Saito, Yasuyuki; Kawamoto, Shinichiro; Yamamoto, Katsuya; Ito, Mitsuhiro; Matsuoka, Hiroshi; Minami, Hironobu.
Affiliation
  • Okuni M; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Yakushijin K; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Uehara K; Department of Diagnostic Pathology, Kobe University Hospital, Japan.
  • Ichikawa H; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Suto H; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Hashimoto A; Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Japan.
  • Tanaka Y; Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Japan.
  • Shinzato I; Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Japan.
  • Sakai R; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Mizutani Y; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Nagao S; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Kurata K; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Kakiuchi S; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Miyata Y; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Inui Y; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Saito Y; Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Japan.
  • Kawamoto S; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Yamamoto K; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Ito M; Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Japan.
  • Matsuoka H; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
  • Minami H; The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan.
Intern Med ; 58(5): 707-712, 2019 Mar 01.
Article in En | MEDLINE | ID: mdl-30449784

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, T-Cell, Peripheral / Hematopoietic Stem Cell Transplantation / Liver Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, T-Cell, Peripheral / Hematopoietic Stem Cell Transplantation / Liver Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2019 Document type: Article Affiliation country: Country of publication: